Kathryn Gordon
Papers
1
Total Citations
29
H-Index
1
About
Kathryn Gordon is a leading surgical researcher whose work centers on improving outcomes in colorectal cancer surgery, with a particular focus on preventing life-threatening complications. Her most notable contribution is the landmark IntAct trial, an unblinded randomised controlled trial investigating the use of intraoperative fluorescence angiography with indocyanine green (ICG) to prevent anastomotic leak in rectal cancer surgery. This study, published in 2025 and already garnering 29 citations, addresses a critical clinical challenge: the high rate of anastomotic leaks that complicate rectal cancer resections. By rigorously evaluating whether ICG fluorescence angiography can safely and effectively reduce this risk, Gordon has provided surgeons with evidence-based guidance on a controversial intraoperative tool. Her work directly impacts patient safety and surgical decision-making, offering a potential strategy to lower morbidity rates. Beyond this trial, Gordon’s research portfolio reflects a deep commitment to translating innovative imaging technologies into practical, life-saving applications. Her findings are essential reading for surgeons and oncologists seeking to optimize surgical precision and reduce postoperative complications.
Research Focus
Key Achievements
Top Papers
- 1